Recalls / Class II
Class IID-1302-2020
Product
oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC 70092-1068-07
- Affected lot / code info
- Lot#: 30010515
Why it was recalled
Subpotent drug - Product did not contain drug.
Recalling firm
- Firm
- QuVa Pharma, Inc.
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 1075 W Park One Dr Ste 100, N/A, Sugar Land, Texas 77478-2576
Distribution
- Quantity
- 648 bags
- Distribution pattern
- USA Nationwide
Timeline
- Recall initiated
- 2020-05-28
- FDA classified
- 2020-06-11
- Posted by FDA
- 2020-06-17
- Terminated
- 2022-01-19
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1302-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.